Related by context. All words. (Click for frequent words.) 78 metastatic castration resistant 76 metastatic castrate resistant 75 prostate cancer HRPC 74 hormone refractory metastatic prostate 74 HER2 positive metastatic breast 74 docetaxel Taxotere R 73 erlotinib Tarceva ® 73 refractory chronic lymphocytic 73 oral ridaforolimus 72 metastatic androgen independent 72 unresectable stage 72 metastatic renal cell 72 Ixempra 72 forodesine 72 metastatic CRPC 72 relapsed refractory multiple myeloma 72 leukemia AML 72 dasatinib Sprycel ® 72 Aflibercept 72 plus prednisone 71 Pemetrexed 71 GW# [003] 71 castrate resistant prostate cancer 71 PSMA ADC 71 stage IIIb IV 71 trastuzumab Herceptin R 71 MAGE A3 ASCI 71 alvespimycin 71 Peginterferon alfa 2b 71 bortezomib Velcade R 71 hormone refractory prostate cancer 71 pertuzumab 71 sorafenib tablets 71 Jevtana 71 relapsed MM 71 FOLFOX6 71 docetaxel Taxotere ® 71 standard chemotherapy regimen 71 castration resistant prostate cancer 71 pegylated liposomal doxorubicin 71 ELACYT 71 Amrubicin 71 paclitaxel Taxol R 71 dasatinib Sprycel 71 AVASTIN 71 BRIM2 70 paclitaxel Taxol 70 sorafenib Nexavar 70 Hormone Refractory Prostate Cancer 70 ZACTIMA 70 mapatumumab 70 gemcitabine Gemzar 70 Navelbine ® 70 recurrent glioblastoma multiforme 70 mRCC 70 adalimumab Humira 70 goserelin 70 metastatic colorectal carcinoma 70 gemcitabine chemotherapy 70 sunitinib malate 70 Nexavar ® 70 SPRYCEL ® 70 relapsed multiple myeloma 70 interferon gamma 1b 70 recurrent NSCLC 70 Tarceva TM 70 lintuzumab SGN 70 advanced metastatic prostate 70 Zytiga 70 phase IIb clinical 70 Phase IIIb clinical 70 Gemzar ® 70 pegylated interferon alpha 70 Velcade bortezomib 70 adriamycin 70 lexidronam injection 70 refractory multiple myeloma 70 metastatic renal cell carcinoma 70 Xeloda ® 69 Degarelix 69 Ozarelix 69 Doxil ® 69 prostate cancer CRPC 69 YONDELIS 69 immunotherapeutic agent 69 metaglidasen 69 refractory metastatic 69 cell lymphoma CTCL 69 gemcitabine Gemzar ® 69 Proxinium TM 69 Daclizumab 69 orally administered inhibitor 69 anthracycline taxane 69 CIMZIA TM certolizumab pegol 69 bevacizumab Avastin ® 69 virus HCV protease inhibitor 69 5 fluorouracil leucovorin 69 vinca alkaloid 69 Annamycin 69 vinorelbine tartrate 69 antibody MAb 69 estramustine 69 Panzem R NCD 69 Cloretazine ® 69 elotuzumab 69 cetuximab Erbitux ® 69 ZOLINZA 69 pegylated interferon alfa 2a 69 luteinizing hormone releasing 69 Meets Primary Endpoint 69 evaluating tivozanib 69 Romidepsin 69 docetaxel chemotherapy 69 assessing T DM1 69 INSPIRE Trial Phase III 69 oral chemotherapeutic agent 69 Ceflatonin 69 investigational immunotherapy 69 AEG# 69 anti EGFR antibody 69 cetuximab Erbitux R 69 receptor tyrosine kinase inhibitor 69 FOLFOX6 chemotherapy regimen 69 paclitaxel Taxol ® 69 IMA# 69 relapsing multiple sclerosis 69 docetaxel Taxotere 69 Sapacitabine 69 PF # [002] 69 leukemia CLL 69 ribavirin RBV 69 PEGINTRON TM 69 alemtuzumab Campath 69 Bezielle 69 PANVAC VF 69 LymphoStat B belimumab 69 PEGylated Fab fragment 69 thetreatment 69 Xelox 69 Onrigin 68 evaluating T DM1 68 docetaxel prednisone 68 CIMZIA ™ 68 galiximab 68 Taxotere ® 68 CIMZIA TM 68 metastatic CRC 68 Temsirolimus 68 metastatic HRPC 68 Nexavar sorafenib 68 temsirolimus 68 capecitabine Xeloda 68 Quinamed 68 Cutaneous T 68 Albuferon TM 68 DOXIL 68 evaluating picoplatin 68 Clolar ® 68 FOLFIRI 68 Intravenous CP 68 Bevacizumab 68 remission induction 68 gefitinib Iressa 68 abiraterone acetate 68 regorafenib 68 vorinostat 68 mTOR inhibitor 68 low dose cytarabine 68 Phase Ib II 68 INCB# [001] 68 phase IIa clinical 68 multi kinase inhibitor 68 Irinotecan 68 resistant hormone refractory 68 previously untreated follicular 68 cyclophosphamide methotrexate 68 Pfizer Sutent 68 Fludarabine 68 Campath alemtuzumab 68 recurrent metastatic 68 metastatic colorectal 68 trabectedin 68 IRESSA 68 Myelodysplastic Syndrome MDS 68 TEMODAL 68 bendamustine 68 FIRMAGON 68 Camptosar ® 68 ACTEMRA TM 68 thalidomide Thalomid 68 Xeloda capecitabine 68 oral deforolimus 68 Traficet EN 68 tanespimycin 68 Vicinium TM 68 Herceptin trastuzumab 68 refractory cutaneous T 68 phase IIb trial 68 Vandetanib 68 ixabepilone 68 stage IIIB 68 Pirfenidone 68 PROSTVAC VF 68 pomalidomide 68 HBeAg negative 68 nucleoside analog 68 infusional 5-FU/LV 68 phase IIb study 68 Cloretazine 68 PNP inhibitor 68 sorafenib Nexavar ® 68 novel VDA molecule 68 Omnitarg 68 Troxatyl 68 neratinib 68 unresectable Stage III 68 8mg/kg 68 Targretin 68 Phase #b/#a clinical 68 Archexin 68 recurrent GBM 68 ORENCIA ® 68 telaprevir dosed 68 Glufosfamide 68 Elotuzumab 68 CYT# potent vascular disrupting 67 Phase Ib study 67 Cimzia TM 67 relapsing remitting MS RRMS 67 recurrent glioblastoma 67 gemcitabine carboplatin 67 Copegus ribavirin 67 atrasentan 67 folinic acid FA 67 acyclovir Lauriad R 67 idarubicin 67 Phase III randomized controlled 67 VNP#M 67 alkylating agent 67 Asentar 67 ritonavir boosted 67 dextromethorphan quinidine 67 severe hypercholesterolemia 67 Tykerb lapatinib 67 EndoTAGTM 1 67 histone deacetylase HDAC inhibitor 67 alfa 2a 67 unresectable locally advanced 67 Pertuzumab 67 relapsed ovarian cancer 67 DEB# 67 docetaxel Injection Concentrate 67 melphalan prednisone 67 comparator arm 67 trastuzumab Herceptin ® 67 dacarbazine 67 LymphoStat B TM 67 Fludara ® 67 rasagiline tablets 67 Brentuximab Vedotin SGN 67 boosted protease inhibitor 67 BENLYSTA TM 67 lenalidomide Revlimid R 67 metastatic pancreatic 67 peginterferon alfa 2a Pegasys 67 IMC A# 67 Advanced Renal Cell 67 pan HDAC inhibitor 67 HGS ETR1 mapatumumab 67 Fulvestrant 67 Rituxan rituximab 67 Phase 2b Clinical Trial 67 advanced unresectable 67 Tezampanel 67 Safinamide 67 baminercept 67 VELCADE melphalan 67 MGd 67 trastuzumab Herceptin 67 trastuzumab DM1 67 lapatinib Tykerb 67 AAG geldanamycin analog 67 RANK Ligand inhibitor 67 reslizumab 67 Pralatrexate 67 Randomized Phase 67 romidepsin 67 Torisel 67 lintuzumab 67 ELOXATIN 67 CR# vcMMAE 67 relapsed leukemia 67 carboplatin chemotherapy 67 somatostatin analog 67 imatinib Gleevec ® 67 KRAS mutations occur 67 HRPC 67 ofatumumab HuMax CD# 67 recurrent malignant glioma 67 custirsen 67 Fibrillex TM 67 chlorambucil 67 cabazitaxel 67 paclitaxel poliglumex 67 systemic ALCL 67 lumiliximab 67 familial amyloidotic polyneuropathy FAP 67 IAP inhibitors 67 carboplatin paclitaxel 67 sunitinib Sutent 67 elacytarabine 67 TroVax ® 67 infliximab monotherapy 67 Hycamtin ® 67 BAY #-# 67 Pegasys ® 67 Abiraterone acetate 67 Panzem R 67 Ophena TM 67 Pivotal Phase 67 TBC# 67 Sanofi Aventis Taxotere 66 Zarnestra 66 IgG1 monoclonal antibody 66 CTAP# Capsules 66 herpetic keratitis 66 advanced hepatocellular carcinoma 66 Camptosar ® irinotecan 66 OMNARIS HFA 66 Phase Ib clinical 66 formerly LymphoStat B 66 lenalidomide dexamethasone 66 octreotide implant 66 beta 1a 66 Neulasta R 66 symptomatic BPH 66 CHOP chemotherapy 66 mertansine 66 active comparator 66 Tipranavir 66 oral prodrug 66 LUX Lung 66 randomized controlled Phase 66 Platinol ® 66 LHRH receptor positive 66 CCX# B 66 RhuDex ® 66 methylnaltrexone 66 Raptiva ® 66 plus dexamethasone 66 gemcitabine Gemzar R 66 oblimersen 66 5-FU/LV 66 evaluating satraplatin 66 bevacizumab Avastin 66 Adjuvant Treatment 66 MDV# 66 HCV RESPOND 2 66 Genasense ® 66 RhuDex TM 66 Paraplatin ® 66 chemotherapy FOLFOX 66 Folfox 66 Taxotere chemotherapy 66 corticosteroid dexamethasone 66 PDE4 inhibitor 66 5 FU leucovorin 66 LEUKINE 66 cetuximab Erbitux 66 CEQ# 66 Dapagliflozin 66 phase Ib 66 Erlotinib 66 CLL SLL 66 ILUVIEN ® 66 Natalizumab 66 fluoropyrimidine 66 Triapine 66 dacarbazine DTIC 66 naïve HCV 66 doxorubicin HCl liposome injection 66 omega interferon 66 cisplatin gemcitabine 66 Cimzia ® certolizumab pegol 66 brivaracetam 66 liposomal doxorubicin 66 omacetaxine mepesuccinate 66 anticancer compound 66 Initiate Phase 66 liposomal formulation 66 MKC# MT 66 essential thrombocythemia ET 66 untreated metastatic colorectal 66 Androxal TM 66 Peg IFN 66 protease inhibitor PI 66 verteporfin 66 refractory AML 66 vemurafenib 66 Taxotere docetaxel 66 IMiDs ® 66 subcutaneously administered 66 CHAMPION PCI 66 hour bronchodilation 66 Phase 2a trial 66 Sprycel dasatinib 66 sargramostim 66 AVOREN 66 Zolinza 66 Aplidin 66 imatinib mesylate Gleevec 66 FUSILEV enhances 66 Hsp# Inhibitor 66 HCV SPRINT 66 Gemcitabine 66 vidofludimus 66 visilizumab 66 opioid induced bowel dysfunction 66 Eli Lilly Gemzar 66 Raptiva R 66 Zorbtive TM 66 novel nucleoside analog 66 heavily pretreated 66 Mitoxantrone 66 Ceflatonin R 66 tocilizumab 66 Pivotal Phase III 66 Prulifloxacin 66 PD LID 66 docetaxel 66 Tarceva erlotinib 66 Bosutinib 66 Vitaxin 66 Telatinib 66 Diabetic Macular Edema DME 66 BRIM3 66 ara C 66 Rebif ® 66 oral rivaroxaban 66 HGS# 66 Temodar ® 66 Vidaza ® 66 BRAF inhibitor 66 biliary tract cancer 66 XYOTAX TM 66 investigational antiplatelet agent 66 Plicera 66 certolizumab 66 plus prednisone prednisolone 66 Aryplase 66 systemic anaplastic large 66 HuMax EGFr 66 CoFactor 66 ongoing Phase 1b 66 Targretin capsules 66 Combination REOLYSIN R 66 refractory CLL 66 epirubicin cyclophosphamide 66 mitoxantrone plus 66 aflibercept VEGF Trap 66 GAMMAGARD 66 PEG SN# 66 metastatic malignant melanoma 66 refractory metastatic colorectal cancer 66 radiation chemoradiation 66 ThermoDox R 66 Phase IIb Trial 66 irinotecan doxorubicin oxaliplatin paclitaxel 66 BCIRG 66 paclitaxel cisplatin 66 rilonacept 65 pediatric acute lymphoblastic 65 cutaneous T 65 ErbB2 positive 65 tenofovir emtricitabine 65 Alocrest 65 vincristine doxorubicin 65 humanized interleukin 6 65 Laquinimod 65 null responder HCV 65 targeting miR 65 abiraterone 65 axitinib 65 oropharyngeal candidiasis OPC 65 targeted antifolate 65 phase III isavuconazole 65 Naive Patients 65 chemotherapeutic regimen 65 Phase IIb trials 65 nab paclitaxel 65 Omacetaxine 65 nucleoside analogue 65 Phase 1b trial 65 ularitide 65 evaluating Actimmune 65 Azilect ® 65 relapsed CLL 65 TASKi2 65 arsenic trioxide injection 65 Myocet 65 HGS ETR1 65 Completes Patient Enrollment 65 ® lenalidomide 65 AEGR 65 MyVax R 65 Renal Cell Carcinoma RCC 65 dose escalation clinical 65 Flu Cy 65 phase IIb 65 multicenter Phase III 65 ALN HPN 65 stage IIIB IV 65 Pfizer Camptosar 65 Oral Fingolimod 65 NMIBC 65 metastatic malignant 65 Pegasys peginterferon alfa 2a 65 Elitek 65 Aplidin R 65 Actemra tocilizumab 65 Thiarabine 65 IMC #B 65 R sorafenib tablets 65 PEGylated interferon beta 1a 65 AVONEX ® 65 IIa trial 65 papillary renal cell carcinoma 65 CLARITY study 65 vandetanib 65 achieved CCyR 65 ISTODAX ® 65 evaluating REVLIMID 65 XELOX 65 Cimzia certolizumab pegol 65 Pegintron 65 pan histone deacetylase 65 OMP #R# 65 TASKi3 65 Betaferon R 65 investigational protease inhibitor 65 aflibercept 65 EGFR expressing mCRC 65 Personalized Immunotherapy 65 Hycamtin 65 metastatic GIST 65 Cloretazine R VNP#M 65 Investigational Treatment 65 Study Evaluating 65 Xcellerated T Cells 65 evaluating Xcytrin 65 androgen receptor antagonist 65 RhuDex R 65 Amplimexon 65 TKB# 65 Lenocta 65 Philadelphia Chromosome Positive 65 cediranib 65 imatinib Gleevec 65 primary hypercholesterolemia 65 Zenvia ™ 65 APEX PD 65 phase IIa 65 virus HCV infection 65 MabCampath 65 sipuleucel T 65 PEG IFN 65 ELND# 65 BCR ABL inhibitor 65 underwent surgical resection 65 Neuvenge 65 registrational trial 65 cutaneous T cell 65 Tanespimycin 65 lenalidomide Revlimid 65 davunetide intranasal AL 65 autologous cellular immunotherapy 65 Diabetic Macular Edema 65 non nucleoside inhibitor 65 metastatic gastric 65 enzastaurin 65 Metastatic Colorectal Cancer 65 blinded randomized placebo controlled 65 peginterferon alpha 2a 65 NVA# 65 Tasigna nilotinib 65 Allovectin 7 65 ARIMIDEX 65 DU #b 65 Trastuzumab DM1 65 Genentech Rituxan 65 mycophenolate mofetil 65 FOLOTYN ® 65 metastatic bladder 65 initiated Phase Ib 65 de novo kidney transplant 65 untreated multiple myeloma 65 investigational monoclonal antibody 65 diagnosed GBM 65 Chemophase 65 OvaRex ® MAb 65 interferon alfa 65 mCRC patients 65 IL# PE#QQR 65 GSK# [001] 65 Peginterferon 65 Saxagliptin 65 delivers fluocinolone acetonide FA 65 atypical Hemolytic Uremic Syndrome 65 novel histone deacetylase 65 Insegia 65 Phase 1b 65 Apaziquone 65 OHR/AVR# 65 IV Busulfex 65 Seliciclib 65 budesonide foam 65 ADVANCE PD 65 TRISENOX 65 dopamine partial agonist 65 azacytidine 65 generation purine nucleoside 65 RoACTEMRA 65 brain metastases originating 65 ADP receptor antagonist 65 KNS # 65 TTF Therapy 65 IRX 2 65 Enzastaurin 65 farletuzumab 65 PRT# 65 androgen independent 65 anthracycline containing 65 SCCHN 65 Camptosar 65 taxane refractory 65 Pazopanib 65 chemotherapy cisplatin 65 anthracyclines taxanes 65 nilotinib Tasigna 65 placebo controlled Phase III 65 HuMax CD4 65 Phase IIa trials 65 Femara letrozole 65 PKC# 65 multicenter Phase II 65 ribavirin therapy 65 PrevOnco ™ 65 demonstrated antitumor activity 65 adult chronic ITP 65 asymptomatic metastatic 65 neoadjuvant treatment 65 bevacizumab Avastin R 65 HDAC Inhibitor 65 castration resistant hormone refractory 65 HuLuc# 65 dexpramipexole 65 sunitinib Sutent ® 65 Interferon beta 1a 65 pegylated interferons 65 Epratuzumab 65 Phase III Clinical Trial 65 non resectable metastatic 65 Voreloxin 65 nucleotide analogue 65 GVAX immunotherapy 65 Phase IIa trial 65 AGILECT R 65 oral anti arrhythmic 65 Lenalidomide 65 Prednisone Against Refractory 65 Relapsed Refractory 65 cyclophosphamide chemotherapy 65 Newly Diagnosed Multiple Myeloma 64 ALN TTR 64 Xanafide 64 FOLFOX chemotherapy 64 modified glutathione analog 64 IIb clinical trial 64 Proellex TM 64 riociguat 64 Capecitabine 64 SinuNase ™ 64 Tocosol Paclitaxel 64 GOUT 64 tumors GIST 64 MKC# MKC# PP 64 Votrient 64 peginterferon alfa 2b 64 adecatumumab 64 Toremifene 64 Platinol 64 REMINYL ® 64 multiple myeloma MM 64 Phase 2b Study 64 atypical antipsychotic medication 64 Mg Usa 64 Arimidex anastrozole 64 Advaxis Phase 64 bicalutamide 64 compound INCB# 64 concurrent chemoradiation 64 FROVA 64 olaparib 64 PEGylated anti 64 non squamous NSCLC 64 CINQUIL 64 calcineurin inhibitor 64 plus DOXIL 64 seliciclib CYC# 64 Pegylated Interferon 64 Sandostatin 64 decitabine 64 GV# [001] 64 anastrozole Arimidex 64 Epothilone D 64 Pivotal Trial 64 CINTREDEKIN BESUDOTOX 64 YONDELIS R 64 INCB# [003] 64 ACAPODENE 64 Hodgkin lymphoma HL 64 thymalfasin 64 Navelbine 64 entinostat 64 targeted radiotherapeutic 64 progressive metastatic prostate 64 diarrhea predominant irritable 64 miconazole Lauriad ® 64 PEG interferon 64 TYGACIL 64 glufosfamide 64 investigational oral inhibitor 64 Initiated Phase 64 Novel Oral 64 First Patient Dosed 64 oral nucleoside analogue 64 long acting muscarinic 64 cyclophosphamide doxorubicin vincristine 64 irbesartan 64 Zevalin R Ibritumomab 64 Tesetaxel 64 anti angiogenic agent 64 taxane resistant 64 Adjuvant chemotherapy 64 Alzhemed TM 64 Belimumab 64 non squamous 64 proteasome inhibitor 64 Onconase 64 KRAS wild 64 huC# DM4 64 abacavir lamivudine 64 SCH # 64 TYKERB 64 EOquin 64 paclitaxel carboplatin 64 Firazyr 64 FOLFOX4 64 TAXOTERE R 64 Melphalan 64 myelodysplastic myeloproliferative diseases 64 Randomized Phase II 64 Neoadjuvant 64 Pegasys plus Copegus 64 OncoVex 64 plus dacarbazine 64 treatment naïve genotype 64 PROVENGE sipuleucel T 64 TLK# 64 Dasatinib 64 agalsidase alfa 64 nilotinib Tasigna ® 64 registrational 64 Bayer HealthCare Onyx Pharmaceuticals 64 EDEMA3 64 Golimumab 64 refractory acute myeloid 64 briakinumab 64 TELINTRA 64 biologic DMARD 64 radiation sensitizer 64 lymphoid malignancies 64 pegylated interferon alfa 64 Bortezomib 64 Phase Ib IIa 64 refractory prostate cancer 64 ZYBRESTAT 64 subcutaneous formulation 64 advanced metastatic renal 64 alpha 2a 64 MT#/MEDI-# 64 Tesmilifene 64 #mg q8h 64 oral vancomycin 64 achieved ACR# 64 PI3K/Akt pathway inhibitor 64 Vicriviroc 64 opioid induced constipation OIC 64 clinically localized prostate 64 Advanced Melanoma 64 immunoconjugate 64 EOquin TM 64 etanercept Enbrel 64 alefacept 64 abatacept Orencia 64 sorafenib Nexavar R 64 HQK 64 EFAPROXYN 64 Anturol TM 64 ketolide antibiotic 64 WX UK1 64 rALLy 64 MYDICAR ® 64 ocular formulation 64 antiretroviral naïve 64 CCR5 antagonist 64 Tiuxetan 64 pharmacologically active isomer 64 prostate cancer AIPC 64 alpha folate receptor 64 Dual Opioid 64 Genasense oblimersen sodium Injection 64 Phase Ib 64 HyperAcute 64 Dendreon investigational 64 Avastin bevacizumab 64 Ridaforolimus 64 plus gemcitabine 64 non resectable 64 evaluating Vectibix 64 highly emetogenic 64 superficial bladder cancer 64 FOLFOX regimen 64 SinuNase TM 64 nonsmall cell lung cancer 64 unresectable tumors 64 FASLODEX 64 Taxol paclitaxel 64 Phase III Pivotal 64 Uricase PEG 64 Revlimid lenalidomide 64 Gleevec imatinib mesylate 64 Ambrisentan 64 Afatinib 64 Mylotarg 64 Phase 2b trial 64 cetrorelix pamoate 64 R# #mg BID 64 hepatocellular cancer 64 PREZISTA r 64 Phase 2b clinical trials 64 Virulizin ® 64 Arzerra ofatumumab 64 Mg Uk 64 K ras mutations 64 Lilly Gemzar 64 taxane chemotherapy 64 talabostat 64 TO AVOID PREGNANCY WHILE 64 TLUS 64 neoadjuvant 64 CLL8 64 Topotecan 64 Imprime PGG 64 Urocidin 64 diabetic neuropathic pain 64 ThermoDox ® 64 Atypical Hemolytic Uremic Syndrome 64 vapreotide acetate 64 SUPPRELIN R LA 64 cyclophosphamide FC 64 candesartan cilexetil 64 Mipomersen 64 Stage IIIB IV 64 agonistic human 64 Dyloject TM 64 Sorafenib 64 E1 INT TM 64 placebo dexamethasone 64 volociximab 64 oxaliplatin Eloxatin 64 immunomodulatory therapy 64 gastrointestinal stromal tumor GIST 64 interferon alfacon 1 64 Heterozygous Familial Hypercholesterolemia 64 cangrelor 64 CANCIDAS 64 anti PlGF 64 accumulate preferentially 64 ALGRX 64 hematological cancers notably 64 rALLy clinical trial 64 CAELYX 64 LHRH agonists 64 Liprotamase 64 Gliadel Wafer 64 ALN VSP Phase 64 Vidaza azacitidine 64 induced macular edema 64 pivotal Phase III 64 monoclonal antibody IgG1 Mab 64 lymphoma CTCL 64 SIR Spheres 64 IMiDs ® compound 64 Inhalation Aerosol 64 Patients Treated With 64 Intervention Effectiveness 64 inhibitor RG# 64 Decitabine 64 tyrosine kinase inhibitor TKI 64 follicular Non Hodgkin 64 stage IIIb 64 multicenter phase 64 PegIFN 64 relapsed refractory AML 64 Clofarabine 64 Gleevec imatinib 64 Syncria R 64 rheumatoid arthritis psoriatic arthritis 64 Phase 1b clinical trials 64 Dementia Related Psychosis 64 NSABP B 64 gastrin analogue TT 64 azilsartan medoxomil 64 Bayer Nexavar 64 Trastuzumab 64 Complicated Skin 64 EGFR expressing metastatic colorectal 64 #mg BID [001] 64 REVLIMID ® 64 Severe Sepsis 64 efavirenz EFV 64 IMiDs R 64 advanced HER2 positive 64 ceftazidime 64 Cetrorelix 64 randomized Phase IIb 64 ribavirin Copegus ® 64 Castration Resistant Prostate Cancer 64 peginterferon alfa 64 BCG refractory carcinoma 64 Initiates Phase II 64 mg administered orally 64 Phase III Trial 64 Vidaza R 64 Eloxatin ® 64 ganetespib 64 monotherapy 64 obatoclax 64 ANYARA 64 KRN# 64 PRTX 64 Tramiprosate ALZHEMED TM 64 Phase IIb Clinical Trial 64 untreated metastatic melanoma 64 fallopian tube carcinoma 64 EGFR TKI 64 postmenopausal osteoporotic women 64 HBeAg + 64 dirucotide 64 terlipressin 64 RELOVAIR ™ 64 Surgical resection 64 Humira adalimumab 64 alpha 2b 64 3 registrational trial 64 VEGFR2 inhibitor 64 NATRECOR R 64 tesmilifene 64 unstable angina UA 63 pegylated alpha interferon 63 PDX pralatrexate 63 humanised monoclonal antibody 63 Ceflatonin ® 63 Bicalutamide 63 Solazed 63 Metastatic Melanoma 63 antiangiogenic therapy 63 nasal calcitonin product 63 multicenter Phase 63 Mepact 63 plus COPEGUS 63 APTIVUS 63 Investigational Oral 63 cytarabine daunorubicin 63 THALOMID 63 Talabostat 63 Combination therapy 63 generation PNP inhibitor 63 ritonavir boosted atazanavir 63 PrevOnco 63 irinotecan containing 63 CML CP 63 Arranon 63 JAK inhibitor 63 R Saizen R 63 humanized therapeutic 63 pegylated interferon peg IFN 63 TNF Tumor Necrosis Factor